Current State and Local Tax Expense (Benefit) of X4 Pharmaceuticals, Inc from 31 Mar 2018 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
X4 Pharmaceuticals, Inc quarterly Current State and Local Tax Expense (Benefit) in USD history and change rate from 31 Mar 2018 to 31 Mar 2024.
  • X4 Pharmaceuticals, Inc Current State and Local Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $0.
Source SEC data
View on sec.gov
Current State and Local Tax Expense (Benefit), Quarterly (USD)

X4 Pharmaceuticals, Inc Quarterly Current State and Local Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2022 Q3
Q1 2021 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q3 2019 $0 $0 01 Jul 2019 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $0 $0 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $0 $0 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q3 2018 $0 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $0 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $0 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.